COVID-19 Update

World

New Cases:   432,028 (⬆︎ .24%)
New Deaths:      8,316 (⬆︎ .21%)

USA

New Cases:   16,949 (⬆︎ .05%)
New Deaths:       315 (⬆︎ .05%)

Yesterday, July 1st, 2021

0 Vaccinated people

and

8,316 Un-Vaccinated people

were killed by COVID-19

181.3 million vaccinated

Including 155.9 million people who have been fully vaccinated in the United States.

In the last week, an average of 1.07 million doses per day were administered, a 45% increase over the week before.

WaPo:

Johnson & Johnson says its coronavirus vaccine is effective against delta variant

The Johnson & Johnson coronavirus vaccine provides effective protection against the delta variant, according to a small study, offering hope to many developing economies facing a summer surge of the highly contagious strand.

Blood samples obtained from eight inoculated people who participated in a laboratory study showed that Johnson & Johnson’s single-dose shot generated a strong immune response against the delta variant, the New Brunswick, N.J.-based company said. (The results have not been peer reviewed.) Earlier clinical trials had shown the vaccine offered 66 percent protection against symptomatic infection.

“We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant,” Paul Stoffels, chief scientific officer at Johnson & Johnson, said in a news release. “This adds to the robust body of clinical data supporting our single-shot vaccine’s ability to protect against multiple variants of concern.”

Why is the Johnson & Johnson vaccine only one shot? Here’s what to know.

The data so far indicates that the three U.S.-approved vaccines offer effective protection against all known variants of the virus. Analysis by British health authorities, drawing on data from a large pool of people, indicates that the Pfizer-BioNTech messenger RNA vaccine provides 96 percent protection against hospitalization from the delta variant, which was first detected in India.

- more -